Anti-ERBB2/HER2/CD340 Antibody (Margetuximab)
Catalog No.
F1429
Anti-ERBB2/HER2/CD340 Antibody (Margetuximab)
Featured Products
Margetuximab (MGAH22) is a chimeric anti-HER2 monoclonal antibody with an optimized Fc domain and an EC50 of 39.33 ng/mL. Margetuximab can be used in metastatic HER2-positive breast cancer research.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
146.1 kDa
Dry ice
1350624-75-7
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
MARGENZA, MGAH22, 4D5
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P04626
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
ERBB2 / HER2 / CD340
Please avoid freeze-thaw cycles.